CeriBell, Inc. Increase (Decrease) in Accounts Payable
CeriBell, Inc. (CBLL) reported Increase (Decrease) in Accounts Payable of $406.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- CeriBell, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.26M, a 24.31% increase year-over-year.
- CeriBell, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$857.00K, a 348.41% decline year-over-year.
- CeriBell, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $589.00K.
- CeriBell, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$205.00K, a 124.09% decline year-over-year.
- CeriBell, Inc. increase (decrease) in accounts payable for fiscal 2025 was $1.75M, a 598.00% increase from fiscal 2024.
- CeriBell, Inc. increase (decrease) in accounts payable for fiscal 2024 was $250.00K, a 19.09% decline from fiscal 2023.
- CeriBell, Inc. increase (decrease) in accounts payable for fiscal 2023 was $309.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $406.00K 10-Q · filed 2026-08-10 | $995.00K derived: sum of 3 quarters · filed 2026-08-10 | $790.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$857.00K 10-Q · filed 2026-05-11 | -$268.00K derived: sum of 2 quarters · filed 2026-05-11 | -$473.00K derived: sum of 3 quarters · filed 2026-05-11 | $543.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $384.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.40M derived: sum of 3 quarters · filed 2026-08-10 | $1.75M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $811.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.16M 10-Q · filed 2025-11-04 | $253.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.36M 10-Q · filed 2026-08-10 | $458.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.31M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $345.00K 10-Q · filed 2026-05-11 | -$558.00K derived: sum of 2 quarters · filed 2026-05-11 | $293.00K derived: sum of 3 quarters · filed 2026-05-11 | $291.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$52.00K derived: sum of 2 quarters · filed 2026-02-24 | -$54.00K derived: sum of 3 quarters · filed 2026-02-24 | $250.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $851.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $849.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.15M 10-Q · filed 2025-11-04 | $614.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $302.00K 10-Q · filed 2025-08-05 | -$237.00K derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $304.00K 10-Q · filed 2025-05-08 | -$235.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $309.00K 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $848.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |